Related references
Note: Only part of the references are listed.Biological characteristics of aging in human acute myeloid leukemia cells: the possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulation
Maria Hernandez-Valladares et al.
Aging-US (2021)
Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions
Nuria Martinez-Cibrian et al.
BLOOD REVIEWS (2021)
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid Leukemia
Anjali S. Advani et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Li Xuan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W. Merryman et al.
LEUKEMIA (2021)
Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid
Maria Hernandez-Valladares et al.
CANCERS (2021)
The Systemic Metabolic Profile Early after Allogeneic Stem Cell Transplantation: Effects of Adequate Energy Support Administered through Enteral Feeding Tube
Tor Henrik Anderson Tvedt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia
Cole Sterling et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia
Dan Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 x 2, Phase II Trial
Michael Luebbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A Pilot Study of Circulating Monocyte Subsets in Patients Treated with Stem Cell Transplantation for High-Risk Hematological Malignancies
Ida Marie Rundgren et al.
MEDICINA-LITHUANIA (2020)
All-Trans Retinoic Acid Inhibits Bone Marrow Mesenchymal Stem Cell Commitment to Adipocytes via Upregulating FRA1 Signaling
Linjun Xie et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor
Eran Zimran et al.
STEM CELLS TRANSLATIONAL MEDICINE (2020)
All-trans retinoic acid and human salivary histatin-1 promote the spreading and osteogenic activities of pre-osteoblasts in vitro
Wei Sun et al.
FEBS OPEN BIO (2020)
Current Trends in ATRA Delivery for Cancer Therapy
Maria Valeria Giuli et al.
PHARMACEUTICS (2020)
All-transretinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
Chi H. Nguyen et al.
CELL CYCLE (2020)
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
Courtney D. DiNardo et al.
LANCET HAEMATOLOGY (2020)
Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid
Stefano Rossetti et al.
CANCERS (2020)
Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells
Chi Huu Nguyen et al.
BIOMEDICINES (2020)
Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation
Burak Kalin et al.
BLOOD ADVANCES (2020)
Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments
Eva Leufven et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Retinoic acid signaling in vascular development
Brad Pawlikowski et al.
GENESIS (2019)
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality
Govindarajan Thangavelu et al.
JOURNAL OF IMMUNOLOGY (2019)
A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma
Guldane Cengiz Seval et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia
Rakel Brendsdal Forthun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission
Samuel D. Slavin et al.
CANCER (2019)
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results
MatthewJ. Wieduwilt et al.
CLINICAL CANCER RESEARCH (2019)
Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype
Annette K. Brenner et al.
CANCERS (2019)
Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation - a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients
Ida Marie Rundgren et al.
BMC IMMUNOLOGY (2019)
Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
Orsola di Martino et al.
CANCERS (2019)
Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy
Ida Sofie Gronningsaeter et al.
CELLS (2019)
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia
Michael R. McKeown et al.
HAEMATOLOGICA (2019)
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
Christina Rautenberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation
Nadja Blagitko-Dorfs et al.
LEUKEMIA (2019)
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
Chi Huu Nguyen et al.
CELL DEATH & DISEASE (2019)
Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant
Abdul Hamid Bazarbachi et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation
Thomas Schroeder et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
Marcos de Lima et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia
Rachel Bosshard et al.
CANCER TREATMENT REVIEWS (2018)
Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation
Sebastian Sommer et al.
LEUKEMIA RESEARCH (2018)
All-Trans Retinoic Acid Induces CD4+CD25+FOXP3+Regulatory T Cells by Increasing FOXP3 Demethylation in Systemic Sclerosis CD4+T Cells
Xiaohong Sun et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Impact of Retinoic Acid on Immune Cells and Inflammatory Diseases
Luana de Mendonca Oliveira et al.
MEDIATORS OF INFLAMMATION (2018)
Role of Vitamin A in the Immune System
Zhiyi Huang et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
Johanna S. Ungerstedt
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
Uwe Platzbecker et al.
LANCET ONCOLOGY (2018)
All-trans retinoic acid can antagonize osteoblastogenesis induced by different BMPs irrespective of their dimerization types and dose-efficiencies
Yi Liu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Thomas Schroeder et al.
ANNALS OF HEMATOLOGY (2018)
Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))
Yasemin Kueley-Bagheri et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Sodium valproate modulates immune response by alternative activation of monocyte-derived macrophages in systemic lupus erythematosus
Saeed Mohammadi et al.
CLINICAL RHEUMATOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
Jan S. Moreb et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Selective histone deacetylase small molecule inhibitors: recent progress and perspectives
Hai-Tao Qin et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function
Sy-Jye Leu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation
Noortje van Gils et al.
EXPERIMENTAL HEMATOLOGY (2017)
Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T-cell immunity
Wei Yin et al.
IMMUNOLOGY (2017)
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ≤ 30% blasts
G. Garcia-Manero et al.
LEUKEMIA (2017)
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
G. Bug et al.
LEUKEMIA (2017)
All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits angiogenesis and metastasis in esophageal squamous cell carcinoma
Na Li et al.
PLOS ONE (2017)
Retinoic Acid and Immune Homeostasis: A Balancing Act
Martje N. Erkelens et al.
TRENDS IN IMMUNOLOGY (2017)
Retinoic Acid and Its Role in Modulating Intestinal Innate Immunity
Paulo Czarnewski et al.
NUTRIENTS (2017)
Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis
Ana Canete et al.
NUTRIENTS (2017)
Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid
Madeleine C. Killer et al.
STEM CELL RESEARCH & THERAPY (2017)
All-Trans Retinoic Acid Promotes an M1-to M2-Phenotype Shift and Inhibits Macrophage-Mediated Immunity to Leishmania major
Natalia S. Vellozo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial
Janghee Woo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells
Gaia Botteri et al.
DIABETOLOGIA (2017)
ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers
Maura Gasparetto et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells
Hakon Reikvam et al.
BMC CANCER (2017)
Serum Vitamin A Levels May Affect the Severity of Ocular Graft-versus-Host Disease
Jiefeng Tong et al.
FRONTIERS IN MEDICINE (2017)
Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children
Dana T. Lounder et al.
BLOOD (2017)
Health-Related Quality of Life of Patients with Acute Myeloid Leukemia: A Systematic Literature Review
Ellen E. Korol et al.
ONCOLOGY AND THERAPY (2017)
Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT
J. El-Cheikh et al.
BONE MARROW TRANSPLANTATION (2017)
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid
Han J. M. P. Verhagen et al.
BLOOD (2016)
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
Richard F. Schlenk et al.
ANNALS OF HEMATOLOGY (2016)
Effects of Donor Vitamin A Deficiency and Pharmacologic Modulation of Donor T Cell Retinoic Acid Pathway on the Severity of Experimental Graft-versus-Host Disease
Joseph Dodge et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis
Stephanie R. Pulliam et al.
CYTOKINE (2016)
Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networks
Frank G. Ruecker et al.
EPIGENETICS (2016)
Panobinostat for the treatment of acute myelogenous leukemia
Fortunato Morabito et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Lost in translation? Ten years of development of histone deacetylase inhibitors in acute myeloid leukemia and myelodysplastic syndromes
Maximilian Stahl et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia
Charles Craddock et al.
HAEMATOLOGICA (2016)
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Nan Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
Helena Boutzen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Valproic acid may exerts its cytotoxic effect through rassf1a expression induction in acute myeloid leukemia
Zare-Abdollahi Davood et al.
TUMOR BIOLOGY (2016)
Retinoic Acid as a Modulator of T Cell Immunity
Maria Rosa Bono et al.
NUTRIENTS (2016)
Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia
Calum Leitch et al.
ONCOTARGET (2016)
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia
Charles Craddock et al.
HAEMATOLOGICA (2016)
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
Adrienne H. Long et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group
Thomas Schroeder et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
Iskra Pusic et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells
Maria Paola Martelli et al.
BLOOD (2015)
Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells
Hiba El Hajj et al.
BLOOD (2015)
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
Olga Grishina et al.
BMC CANCER (2015)
Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia
S. Kurosawa et al.
BONE MARROW TRANSPLANTATION (2015)
5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft
J. Steinmann et al.
BONE MARROW TRANSPLANTATION (2015)
Health Care Utilization and End-of-Life Care for Older Patients With Acute Myeloid Leukemia
Areej R. El-Jawahri et al.
CANCER (2015)
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
Enrique M. Ocio et al.
HAEMATOLOGICA (2015)
Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut
Myung H. Kim et al.
IMMUNITY (2015)
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
Enrique M. Ocio et al.
HAEMATOLOGICA (2015)
Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid
Elisabeth Ersvaer et al.
BMC PHARMACOLOGY & TOXICOLOGY (2015)
Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia
Gaku Oshikawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment
Meng Su et al.
PLOS ONE (2015)
End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia
Hon-Wai Benjamin Cheng et al.
SUPPORTIVE CARE IN CANCER (2015)
Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT
B. Tessoulin et al.
BONE MARROW TRANSPLANTATION (2014)
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid
Birgit Steinmetz et al.
CELL CYCLE (2014)
Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Chindu Govindaraj et al.
CLINICAL CANCER RESEARCH (2014)
Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study
Annemieke Leunis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function
Jessy Arbez et al.
IMMUNOBIOLOGY (2014)
Modulation of T Cell and Innate Immune Responses by Retinoic Acid
Mathilde Raverdeau et al.
JOURNAL OF IMMUNOLOGY (2014)
Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells
Zhi-Hua Zhang et al.
MOLECULAR MEDICINE REPORTS (2014)
Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity
Sook-Kyoung Heo et al.
PLOS ONE (2014)
Epigenetic therapy of cancer with histone deacetylase inhibitors
K. C. Lakshmaiah et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease
Xiao Chen et al.
BLOOD (2013)
Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?
Hakon Reikvam et al.
CURRENT CANCER DRUG TARGETS (2013)
Regulation of Primitive Hematopoiesis by Class I Histone Deacetylases
Rishita R. Shah et al.
DEVELOPMENTAL DYNAMICS (2013)
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies
D. J. DeAngelo et al.
LEUKEMIA (2013)
Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
Chengzhi Xie et al.
PLOS ONE (2013)
The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia
Hanne Fredly et al.
CLINICAL EPIGENETICS (2013)
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents
Hanne Fredly et al.
CLINICAL EPIGENETICS (2013)
Vitamin A and retinoic acid in T cell-related immunity
A. Catharine Ross
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment
Hanne Fredly et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
HDAC inhibitor therapy in autoimmunity and transplantation
Wayne W. Hancock et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
A Prospective Study Comparing the Outcomes and Health-Related Quality of Life in Adult Patients with Myeloid Malignancies Undergoing Allogeneic Transplantation Using Myeloablative or Reduced-Intensity Conditioning
Vikas Gupta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Anticarcinogenic Actions of Tributyrin, A Butyric Acid Prodrug
Renato Heidor et al.
CURRENT DRUG TARGETS (2012)
Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial
Katja Sockel et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Impact of valproic acid on dendritic cells function
Jihane Frikeche et al.
IMMUNOBIOLOGY (2012)
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
E. McCormack et al.
LEUKEMIA (2012)
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
U. Platzbecker et al.
LEUKEMIA (2012)
Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity
Steven Lane et al.
LEUKEMIA & LYMPHOMA (2012)
Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells
Danian Nie et al.
LEUKEMIA & LYMPHOMA (2012)
Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells
Chengzhi Xie et al.
PEDIATRIC BLOOD & CANCER (2012)
Shift of Graft-Versus-Host-Disease Target Organ Tropism by Dietary Vitamin A
Christian Koenecke et al.
PLOS ONE (2012)
Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid
Rakel Brendsdal Forthun et al.
PLOS ONE (2012)
Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells
Ai-Hua Wang et al.
ANNALS OF HEMATOLOGY (2011)
Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway
Sebastien Chateauvieux et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate-or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
Michael Luebbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C
M. T. Corsettia et al.
LEUKEMIA RESEARCH (2011)
The chemokine system. in allogeneic stem-cell transplantation: a possible therapeutic target?
Guro Kristin Melve et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
Andrea Kuendgen et al.
CLINICAL EPIGENETICS (2011)
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA
Alan K. Burnett et al.
BLOOD (2010)
5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
A. Czibere et al.
BONE MARROW TRANSPLANTATION (2010)
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allografting
M. Luebbert et al.
BONE MARROW TRANSPLANTATION (2010)
Maintenance Therapy With Low-Dose Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for Recurrent Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Marcos de Lima et al.
CANCER (2010)
Mechanisms of Synergistic Antileukemic Interactions between Valproic Acid and Cytarabine in Pediatric Acute Myeloid Leukemia
Chengzhi Xie et al.
CLINICAL CANCER RESEARCH (2010)
Toll-Like Receptor Ligands Cause Proinflammatory and Prodiabetic Activation of Adipocytes via Phosphorylation of Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase But Not Interferon Regulatory Factor-3
Andrea Kopp et al.
ENDOCRINOLOGY (2010)
Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia - a report of five cases
Hanne Fredly et al.
HEMATOLOGY (2010)
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Sebastien Chateauvieux et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities
Stefan Groeschel et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Valproic acid exerts differential effects on CXCR4 expression in leukemic cells
Hilal Gul et al.
LEUKEMIA RESEARCH (2010)
Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response
Sonja C. Bingemann et al.
FEBS JOURNAL (2009)
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B
Richard F. Schlenk et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis
Akio Kawakami et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid
Anita Ryningen et al.
LEUKEMIA RESEARCH (2009)
ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?
M. S. Thakar et al.
Hematology-American Society of Hematology Education Program (2009)
High EVI1 levels predict adverse outcome in acute myeloid leukemia:: prevalence of EVI1 overexpression. and chromosome 3q26 abnormalities underestimated
Sanne Lugthart et al.
BLOOD (2008)
In vivo biological effects of ATRA in the treatment of AML
Anita Ryningen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Expression and prognostic significance of different mRNA 5 ' - End variants of the oncogene EVII in 266 patients with de novo AML: EVII and MDSI/EVII overexpression both predict short remission duration
Katja Haas et al.
GENES CHROMOSOMES & CANCER (2008)
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia
Doyle Messerer et al.
HAEMATOLOGICA (2008)
Deacetylase inhibition promotes the generation and function of regulatory T cells
Ran Tao et al.
NATURE MEDICINE (2007)
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
MNI overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML
Michael Heuser et al.
BLOOD (2007)
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Alessio Nencioni et al.
CLINICAL CANCER RESEARCH (2007)
Targeting AML1/ETO-histone deacetylase repressor complex: A novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells
Shujun Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia
Francesco Fazi et al.
BLOOD (2007)
Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia
Gesine Bug et al.
HAEMATOLOGICA (2007)
Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
O. Bruserud et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Valproic acid malignancies for the treatment of myeloid
Andrea Kuendgen et al.
CANCER (2007)
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
Guillermo Garcia-Manero et al.
BLOOD (2006)
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia
Giuseppe Cimino et al.
CANCER RESEARCH (2006)
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies
Francis Giles et al.
CLINICAL CANCER RESEARCH (2006)
Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation
Daniela Passeri et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Synergistic induction of folate receptor β by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells:: Mechanism and utility in enhancing selective growth inhibition by antifolates
Huiling Qi et al.
CANCER RESEARCH (2006)
Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane
MC Myzak et al.
CURRENT DRUG TARGETS (2006)
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination moth all-trans retinoic acid in patients with acute myeloid leukemia
A Kuendgen et al.
CANCER (2006)
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia
G Bug et al.
CANCER (2005)
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia
A Kuendgen et al.
ANNALS OF HEMATOLOGY (2005)
Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors
HH Cho et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors
C Bradbury et al.
LEUKEMIA (2005)
Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-ends
M Aytekin et al.
GENE (2005)
The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells
MR Trus et al.
LEUKEMIA (2005)
Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells
G Bug et al.
CANCER RESEARCH (2005)
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
RF Schlenk et al.
LEUKEMIA (2004)
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A cancer and leukemia group B study
AB Kornblith et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Hematologic toxicity of sodium valproate
S Acharya et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2000)
Share Paper
